✦ LIBER ✦

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

✍ Scribed by Margaret Van Heek; Constance Farley; Douglas S Compton; Lizbeth Hoos; Kevin B Alton; Edmund J Sybertz; Harry R Davis Jr

Book ID: 110004914
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 183 KB
Volume: 129
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0703235

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism and structure activity data b

Metabolism and structure activity data based drug design: discovery of (−) SCH 53079 an analog of the potent cholesterol absorption inhibitor (−) SCH 48461

✍ Syndeep Dugar; Nathan Yumibe; John W. Clader; Monica Vizziano; Keith Huie; Marga 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Gamma-lactams and related compounds as c

Gamma-lactams and related compounds as cholesterol absorption inhibitors: homologs of the beta-lactam cholesterol absorption inhibitor SCH 484611

✍ Sundeep Dugar; Michael P. Kirkup; John W. Clader; Sue-Ing Lin; Razia Rizvi; Mark 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Our search for potent cholesterol absorption inhibitors led to the discovery of the I~-lactam SCH 48461. Structure activity relationship studies prompted us to this study of y-lactams, ring homologs of 13lactam SCH 48461, to determine their potential as cholesterol absorption inhibitors. The results

ChemInform Abstract: Metabolism and Stru

ChemInform Abstract: Metabolism and Structure Activity Data Based Drug Design: Discovery of (-)SCH 53079 (Ia), an Analogue of the Potent Cholesterol Absorption Inhibitor (-)SCH 48461 (Ib).

✍ S. DUGAR; N. YUMIBE; J. W. CLADER; M. VIZZIANO; K. HUIE; M. VAN HEEK; D. S. COMP 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 27 KB

Effect of the cholesterol absorption inh

Effect of the cholesterol absorption inhibitor SCH48461 in combination with the HMG-CoA reductase inhibitor lovastatin in rabbits, dogs and rhesus monkeys

✍ H.R. Davis; R.W. Watkins; B.G. Salisbury; D.S. Compton; E.J. Sybertz; R.E. Burri 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Disposition of the cholesterol absorptio

Disposition of the cholesterol absorption inhibitor ezetimibe in mdr1a/b (−/−) mice

✍ Stefan Oswald; Christiane Koll; Werner Siegmund 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The lipid lowering agent ezetimibe (EZ) and its intestinally formed glucuronide (GLUC) were shown to be substrates of the efflux transporters P-glycoprotein (P-gp) and the multidrug resistance associated protein 2 (MRP2) which markedly influences the disposition and efficacy of EZ in man. This study

The novel cholesterol absorption inhibit

The novel cholesterol absorption inhibitor, ezetimibe, selectively inhibits the intestinal absorption of free cholesterol in the presence and absence of exocrine pancreatic function

✍ M. van Heek; C. Farley; D. Compton; L. Hoos; H. Davis 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 172 KB